[Results of low-dose treatment of XXXX with @entity4082 ].

@entity1 @entity251 @entity1792 @entity4082 @entity948 @entity53 @entity6660
30 @entity6660 @entity1 from the andrologic outpatient service of the University-Hospital for Gynecology and Obstetrics, Graz, Austria, received a treatment with @entity4082 - @entity1792 . A doses of 25 mg daily was given for 25 days, followed by a break of 5 days. This treatment cycle was repeated three times, providing a total of 4 months of therapy. Rigid criteria of selection were applied for the @entity1 in this trial, pretreatment serum levels of FSH, LH, @entity251 , prolactin and @entity53 had to be in normal or low-normal range. After treatment FSH, LH and @entity251 were re-evaluated and a semen analysis was performed. Six to eight weeks afterwards another spermiogram was done. A significant raise of sperm density was observed immediately after treatment and at the control 6-8 weeks after therapy. Motility and morphologic quality remained unchanged after the therapeutic course. @entity948 content of seminal plasma raised significantly 6-8 weeks after therapy. FSH, LH and @entity251 increased also on a significant level. 6 pregnancies could be achieved, no negative side effects of treatment had to be registered.
